Article Details
Retrieved on: 2025-04-11 10:35:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The JAK 1/2 inhibitor was approved by the FDA in July 2024 for treatment of adults with severe alopecia areata (AA); however, a patent ruling in ...
Article found on: www.globaldata.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here